Ep. 60 - Public opinions on Wegovy and other weight loss drugs

Matthew Handley and Ron Howrigon discuss the ongoing relevance of COVID, the cost of weight loss drugs in the US, and public opinion on prescription weight loss drugs. Key highlights COVID still matters, especially for those at riskThe cost of weight loss drugs in the US compared to other countriesThe need for a free market economy in healthcarePublic opinion on prescription weight loss drugsThe potential impact of covering weight loss drugs under insurance Resources mentioned Health System Tracker - How do prices of drugs for weight loss in the U.S. compare to peer nations’ prices?Kaiser Family Foundation - KFF Health Tracking Poll July 2023: The Public’s Views Of New Prescription Weight Loss Drugs And Prescription Drug Costs Facts COVID can still be severe for at-risk populationsVaccines can help prevent severe symptomsThe US pays more for weight loss drugs compared to other countriesThe prevalence of obesity is high in the USThe cost of covering weight loss drugs for all Americans would be significant Action steps Stay informed about the ongoing impact of COVIDConsider the cost of weight loss drugs and explore alternative optionsShare your opinion on prescription weight loss drugsAdvocate for healthcare policies that promote a free market economy   Listener challenge: Reflect on your own opinion about prescription weight loss drugs and consider the potential impact of covering them under insurance.   Matthew Handley on XRon Howrigon on X Subscribe to the Flatlining Podcast to never miss an episode and join the conversation about important healthcare topics. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.flatlining.net